Pulmonary inflammation in rats after intratracheal instillation of quartz, amorphous SiO2, carbon black, and coal dust and the influence of poly-2-vinylpyridine-N-oxide (PVNO).

Effects of poly-2-vinylpyridine-N-oxide (PVNO) were investigated in numerous in vivo and in vitro studies published in the nineteen sixties and seventies. These studies showed that PVNO inhibited development of fibrosis from quartz dust and improved lung clearance of quartz after inhalation exposure. Ameliorating effects of PVNO were observed also for pulmonary damage from colloidal SiO2 and organic substances, and the fibrogenic inflammation caused by carrageenan. Although it is not proven that silicosis is a precondition for quartz-induced lung tumours, we investigated the hypothesis that PVNO could reduce the lung tumour risk from quartz in rats. A carcinogenicity study was therefore started in rats with the main focus on the quantitative relationships among pulmonary inflammation, fibrosis and neoplasia caused by intratracheal instillation of 3 mg quartz DQ 12 with or without additional subcutaneous PVNO treatment. Other study groups were treated with multiple dust instillations, i.e. 30 instillations of 0.5 mg amorphous SiO2 at intervals of 2 weeks, 10 instillations of 0.5 mg of ultrafine carbon black or 1 mg coal at weekly intervals. The analyses of the bronchoalveolar lavage fluid (BALF) 9 months after start of the life-time study showed that the aim of producing similar levels of increased enzyme concentrations in the four groups treated with quartz/PVNO, amorphous SiO2, carbon black and coal was achieved. A 2.5- to 7.7-fold increase for lactate dehydrogenase (LDH), total protein, alkaline phosphatase and gamma-glutamyl transferase (gamma-GT) was found in these groups as compared to the control. In contrast, quartz treatment without PVNO increased the LDH level up to 24-fold and of total protein to 13-fold. However, the cell counts in the BALF were not so much different in all five groups, i.e. quartz without PVNO (leukocytes: 480.000, PMN: 190.000), quartz with PVNO (leukocytes: 300.000, PMN: 100.000), amorphous SiO2 (leukocytes: 570.000, PMN: 315.000), carbon black (leukocytes: 390.000, PMN: 150.000) and coal (leukocytes: 200.000, PMN: 65.000). Histopathological investigations after four weeks and three months revealed that the used PVNO sample was active in the quartz and amorphous SiO2 groups and markedly reduced the incidences or severity of several pulmonary changes such as macrophage accumulation, inflammatory cell infiltration, interstitial fibrosis, bronchiolo-alveolar hyperplasia, alveolar lipoproteinosis and amorphous SiO2 -induced granulomatous alveolitis/interstitial fibrotic granulomas. Also in the lung-associated lymph nodes (LALN), PVNO treatment significantly reduced the incidence and severity of inflammation in both quartz and amorphous SiO2 groups as evidenced by the presence of well-circumscribed aggregates of intact particle-laden macrophages without signs of degeneration and accompanying granulocytic infiltration and fibrosis. Immunological investigations at the 9 months timepoint on the in vitro production of reactive nitrogen (RNI) or oxygen (ROI) intermediates and tumour necrosis factor (TNF-alpha) from BALF-derived cells indicated a diminished responsiveness to LPS in all particle treatment groups. A diminished production of ROI was also found in the quartz, carbon black, and coal dust groups, respectively, as compared to the values seen in the quartz/PVNO- and amorphous SiO2 treated groups. Treatment with quartz plus PVNO restored the capability of the cells to respond to LPS as compared to the treatment with quartz alone. TNF-alpha production was diminished in the groups treated with quartz, carbon black, and coal dust alone whereas in the quartz/PVNO- and amorphous SiO2-treated groups an elevated TNF-alpha production was seen. These results led to the conclusion that only amorphous SiO2 did not affect the "normal" ability of the cells to respond to LPS and that PVNO protected the cells from a toxic effect of the quartz particles.

[1]  M. O’Reilly,et al.  Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  J. Carter,et al.  Cytokines and particle-induced inflammatory cell recruitment. , 1997, Environmental health perspectives.

[3]  G. Canonica,et al.  Intercellular adhesion molecule‐1 on cultured human epithelial cell lines: influence of proinflammatory cytokines , 1997, Allergy.

[4]  R. Devlin,et al.  Stimulation of human and rat alveolar macrophages by urban air particulates: effects on oxidant radical generation and cytokine production. , 1996, Toxicology and applied pharmacology.

[5]  D. Remick,et al.  Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates , 1996, Journal of leukocyte biology.

[6]  F. Hahn,et al.  Noncarcinogenic Responses of the Respiratory Tract to Inhaled Toxicants , 1995 .

[7]  Rogene F. Henderson,et al.  Concepts In Inhalation Toxicology , 1995 .

[8]  B. Fischer,et al.  Interactions of oxygen radicals with airway epithelium. , 1994, Environmental health perspectives.

[9]  R. Strieter,et al.  Acute lung injury: the role of cytokines in the elicitation of neutrophils. , 1994, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[10]  H. Joenje,et al.  Genetic toxicology of oxygen. , 1989, Mutation research.

[11]  A. G. Heppleston Pulmonary toxicology of silica, coal and asbestos. , 1984, Environmental health perspectives.

[12]  V. Devita,et al.  IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. , 1980, American Industrial Hygiene Association journal.

[13]  W. Weller Long-term test on rhesus monkeys for the PVNO therapy of anthracosilicosis. , 1975, Inhaled particles.

[14]  K. Stalder,et al.  Zur Verteilung, Speicherung und Ausscheidung von tritiummarkiertem Poly-2-vinylpyridin-N-oxid , 1971 .

[15]  F. Pott,et al.  Tierexperimentelle Grundlagen zur medizinischen Silikoseprophylaxe mit Polyvinylpyridin-N-oxid (P 204) , 1968 .

[16]  J. Ottowicz,et al.  THE EFFECT OF POLYVINYL-PYRIDINE-N-OXIDE TREATMENT ON THE DEVELOPMENT OF EXPERIMENTAL SILICOSIS. , 1964, Annals of Occupational Hygiene.

[17]  H W SCHLIPKOETER,et al.  [The effects of polyvinylpyridine on experimental silicosis]. , 1960, Deutsche medizinische Wochenschrift.

[18]  W. Kaufmann,et al.  RITA--registry of industrial toxicology animal-data--guides for organ sampling and trimming procedures in rats. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[19]  P. Germann,et al.  Lung Tumours in Rats after Intratracheal Instillation of Dusts , 1994 .

[20]  J. Mauderly,et al.  Toxic and carcinogenic effects of solid particles in the respiratory tract , 1994 .

[21]  W. Koch,et al.  Subchronic Inhalation Study of Toner in Rats , 1990 .

[22]  R. Henderson,et al.  Comparative study of bronchoalveolar lavage fluid: effect of species, age, and method of lavage. , 1987, Experimental lung research.

[23]  E. Beck Die Reaktion in vitro gezüchteter Zellen auf partikelförmige Luftverunreinigungen und hochpolymere Stoffe , 1970 .

[24]  F. Pott,et al.  Experimental prevention of silicosis by inhalation of polyvinylpyridine-N-oxide (P 204) aerosol. , 1968 .